P32 Sodium Phosphate (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the P32 Sodium Phosphate drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
| NON-PROPRIETARY NAME: | P32 Sodium Phosphate |
| SUBSTANCE NAME: | PHOSPHORUS P-32 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-06-19 |
| END MARKETING DATE: | 0000-00-00 |
P32 Sodium Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | P32 Sodium Phosphate from AnazaoHealth Corporation |
| LABELER NAME: | AnazaoHealth Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mCi/4mL) |
| START MARKETING DATE: | 2012-06-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51808-128_c099d1ae-d9f6-4176-b55c-233ce52b2976 |
| PRODUCT NDC: | 51808-128 |
| APPLICATION NUMBER: | |
Other PHOSPHORUS P-32 Pharmaceutical Manufacturers / Labelers:
